comprehensive -WSS

comprehensive

author：explore 2025-10-01 15:28:15 - browse：91748

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： 7 people shot in DC, police say

focus

WSS

Listen: Biogen's messy board & Laronde's data problem

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Helping hospitals and community health centers plan for resilience

Criminal prosecution for violating HIPAA: an emerging threat

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Case highlights the risks of experimental stem cell therapy

entertainment

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

7 people shot in DC, police say

The cancer drug shortage isn’t new — and neither are the solutions

It's time to retire 'poor historian' from clinicians' vocabularies

Apple is now the first public company to be valued at $3 trillion

Make 'food is medicine' a key part of White House nutrition meeting

23andMe had bad news about my health. I wish a person had delivered it

Solving academic medical centers' existential crisis

Drug repurposing or repositioning? The language matters

Wearables generate powerful data but its not useful to doctors, yet

Wikipedia

These geoengineering technologies could help combat the climate crisis, scientists say

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Listen: Biogen's messy board & Laronde's data problem

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Arc Institute generative AI designs new CRISPR systems

Inside the fall of star MIT scientist David Sabatini

knowledge

knowledge

focus

focus